These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

917 related items for PubMed ID: 31340702

  • 21. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J.
    J Natl Cancer Inst; 2004 Feb 18; 96(4):280-93. PubMed ID: 14970277
    [Abstract] [Full Text] [Related]

  • 22. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
    Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE.
    Lancet Oncol; 2011 Jul 18; 12(7):663-72. PubMed ID: 21684207
    [Abstract] [Full Text] [Related]

  • 23. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
    Guo M, Shlyakhova N, Khanna A, Tinnirello AA, Schmeler KM, Hwang J, Sturgis EM, Stewart J.
    J Am Soc Cytopathol; 2021 Jul 18; 10(4):399-405. PubMed ID: 33967024
    [Abstract] [Full Text] [Related]

  • 24. HPV testing with cytology triage for cervical cancer screening in routine practice.
    Louvanto K, Chevarie-Davis M, Ramanakumar AV, Franco EL, Ferenczy A.
    Am J Obstet Gynecol; 2014 May 18; 210(5):474.e1-7. PubMed ID: 24373948
    [Abstract] [Full Text] [Related]

  • 25. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M, Wright TC, Stoler MH, Ranger-Moore J, Rehm S, Aslam S, Fang Q, Volkir P, Ridder R.
    Am J Obstet Gynecol; 2021 Sep 18; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [Abstract] [Full Text] [Related]

  • 26. Cervicography and HPV DNA testing as triage criteria for patients with abnormal pap smear.
    Costa S, Sideri M, Bucchi L, Schettino F, Maini I, Spinaci L, Bovicelli L, Terzano P.
    Gynecol Oncol; 1998 Dec 18; 71(3):404-9. PubMed ID: 9887239
    [Abstract] [Full Text] [Related]

  • 27. HPV testing in primary screening of older women.
    Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.
    Br J Cancer; 1999 Oct 18; 81(3):554-8. PubMed ID: 10507785
    [Abstract] [Full Text] [Related]

  • 28. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M.
    Cochrane Database Syst Rev; 2017 Aug 10; 8(8):CD008587. PubMed ID: 28796882
    [Abstract] [Full Text] [Related]

  • 29. Is there a role for cervicography in the detection of premalignant lesions of the uterine cervix?: a Brazilian experience.
    Gasperin P, Francisco JA, Tizzot EL, Curcio L, Couto Filho Jd, Moreira PR, Pascotini CM, de Azevedo EM, Coibion M, Budel VM, de Carvalho NS.
    J Low Genit Tract Dis; 2012 Oct 10; 16(4):387-93. PubMed ID: 22659773
    [Abstract] [Full Text] [Related]

  • 30. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S, Steinberg W, Schneider W, Hanrath C.
    J Clin Virol; 2009 Nov 10; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [Abstract] [Full Text] [Related]

  • 31. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK, Luo XP, Li ZF, Su Z, Xia JC, Hu GY, Zhu YJ, Xie LX, Feng XX, Sun XB, Chen W, Qiao YL.
    Zhonghua Zhong Liu Za Zhi; 2020 Mar 23; 42(3):252-256. PubMed ID: 32252206
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 23; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 34. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ.
    JAMA; 2018 Jul 03; 320(1):43-52. PubMed ID: 29971397
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Aided visual inspection with acetic acid (VIA) and HPV detection as optional screening tools for cervical cancer and its precursor lesions.
    Bragança JF, Derchain SF, Sarian LO, Messias da Silva SM, Labatte S, Zeferino LC.
    Clin Exp Obstet Gynecol; 2005 Jul 03; 32(4):225-9. PubMed ID: 16440819
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Epidemiology Characteristics and Potential Cervical Cancer Screening Value of Vulvar Human Papillomavirus in Chinese Women: A Multicenter Cross-Sectional Study.
    Li X, Xie H, Fu Y, Zhang X, Dong X, Ji Y, Lu W, Wang X.
    Arch Pathol Lab Med; 2024 Sep 01; 148(9):1035-1040. PubMed ID: 38059501
    [Abstract] [Full Text] [Related]

  • 40. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N, Othman NH.
    Asian Pac J Cancer Prev; 2014 Sep 01; 15(5):2245-9. PubMed ID: 24716964
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.